HR8857119th Congress

To amend title XI of the Social Security Act to adjust which engineered cyclic peptides are qualifying single source drugs for purposes of the Drug Price Negotiation Program.

Sponsored By: Representative Morelle, Joseph D. [D-NY-25]

Introduced

Summary

No summary available.

Your PRIA Score

Score Hidden

Personalized for You

How does this bill affect your finances?

Sign up for a PRIA Policy Scan to see your personalized alignment score for this bill and every other piece of legislation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.

Free to start

Bill Overview

No Economic Impacts Identified for this Bill

Sponsors & CoSponsors

Sponsor

Morelle, Joseph D. [D-NY-25]

NY • D

Cosponsors

  • Rep. Gottheimer, Josh [D-NJ-5]

    NJ • D

    Sponsored 5/15/2026

  • Pfluger

    TX • R

    Sponsored 5/15/2026

  • Kean

    NJ • R

    Sponsored 5/15/2026

Roll Call Votes

No roll call votes available for this bill.

View on Congress.gov
Back to Legislation